Homatropine Hydrobromide

Basic Information

Item Value
DrugBank ID DB11181
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 23

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 cauda equina syndrome KG + DL
2 obsolete neurogenic bladder (disease) KG + DL
3 gastroduodenitis KG + DL
4 overactive bladder (disease) KG + DL
5 gastroenteritis KG + DL
6 dysautonomia KG + DL
7 nasal cavity disease KG + DL
8 acute laryngopharyngitis KG + DL
9 large intestine disease KG + DL
10 pharyngitis KG + DL
11 small intestine disease KG + DL
12 autonomic nervous system disease KG + DL
13 bile duct disease KG + DL
14 dermatitis KG + DL
15 acrodermatitis chronica atrophicans KG + DL
16 neonatal dermatomyositis KG + DL
17 bile duct neoplasm KG + DL
18 secondary interstitial lung disease specific to childhood associated with a connective tissue disease KG + DL
19 amyopathic dermatomyositis KG + DL
20 common cold KG + DL
21 acne keloid KG + DL
22 enterocolitis (disease) KG + DL
23 hydroa vacciniforme, familial KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.